- JP-listed companies
- Fuji Pharma Co.,Ltd.
Fuji Pharma Co.,Ltd.JP:4554
Market cap
¥31.9B
P/E ratio
9.3x
| Sep 30, 2013 | Sep 30, 2014 | Sep 30, 2015 | Sep 30, 2016 | Sep 30, 2017 | Sep 30, 2018 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | Sep 30, 2023 | |
| Profit (loss) before income taxes | 3,332 | 3,232 | 3,105 | 3,148 | 4,530 | 4,472 | 3,961 | 2,918 | 3,371 | 3,723 | 4,399 |
| Depreciation | 1,206 | 1,376 | 1,768 | 1,667 | 1,769 | 1,976 | 1,850 | 1,774 | 1,828 | 2,462 | 2,707 |
| Amortization of goodwill | 207 | 277 | 311 | 254 | 254 | 275 | 279 | 283 | 278 | 283 | 316 |
| Increase (decrease) in allowance for doubtful accounts | -2 | -2 | - | - | - | - | -6 | - | - | - | - |
| Increase (decrease) in provision for bonuses | 265 | -3 | -167 | 16 | 116 | 286 | -305 | -424 | 540 | 8 | -109 |
| Increase (decrease) in provision for bonuses for directors (and other officers) | 7 | -1 | -9 | -4 | - | 4 | -6 | -1 | 3 | - | 1 |
| Increase (decrease) in retirement benefit liability | - | 101 | 61 | 81 | 58 | 108 | 156 | 180 | 99 | 64 | 94 |
| Interest and dividend income | -9 | -2 | -2 | -1 | -1 | -2 | -3 | -1 | -7 | -44 | -79 |
| Interest expenses | 55 | 50 | 37 | 35 | 34 | 38 | 41 | 37 | 53 | 77 | 107 |
| Foreign exchange losses (gains) | -116 | -54 | 29 | 243 | -280 | -9 | 97 | 104 | 28 | -217 | -116 |
| Loss (gain) on valuation of derivatives | - | - | - | - | - | - | - | - | - | 287 | -364 |
| Loss on retirement of non-current assets | - | - | 4 | 135 | 20 | 5 | 18 | 69 | 22 | 1 | 4 |
| Decrease (increase) in trade receivables | 809 | -1,880 | -722 | -796 | -1,982 | -1,731 | 3,965 | 1,203 | -174 | -549 | -3,705 |
| Decrease (increase) in inventories | 546 | -2,568 | -2,250 | -240 | 185 | 235 | 581 | -23 | -1,340 | -3,618 | -3,395 |
| Increase (decrease) in trade payables | -1,320 | 2,990 | -537 | 240 | -642 | 994 | -1,937 | -1,102 | 2,038 | 447 | -652 |
| Decrease (increase) in long-term advance payments | - | - | - | - | - | -968 | -16 | - | -86 | -56 | - |
| Other, net | - | 768 | 22 | 661 | 312 | -46 | -828 | 1,515 | 443 | -1,702 | 3,678 |
| Subtotal | 5,048 | 4,283 | 1,645 | 5,441 | 4,375 | 5,639 | 7,925 | 6,533 | 6,957 | 878 | 2,887 |
| Interest and dividends received | 10 | 9 | - | 2 | 2 | 2 | 3 | 1 | 7 | 44 | 79 |
| Interest paid | -61 | -60 | -44 | -58 | -45 | -70 | -53 | -41 | -59 | -82 | -104 |
| Income taxes paid | -1,366 | -1,474 | -1,010 | -874 | -1,094 | -1,797 | -957 | -723 | -911 | -1,498 | -946 |
| Net cash provided by (used in) operating activities | 3,630 | 2,757 | 589 | 4,509 | 3,238 | 3,773 | 7,035 | 5,770 | 5,993 | -658 | 1,917 |
| Purchase of property, plant and equipment | -2,779 | -1,079 | -1,512 | -2,308 | -1,477 | -1,446 | -1,701 | -2,322 | -3,789 | -5,097 | -3,327 |
| Proceeds from sale of property, plant and equipment | - | - | 2,508 | 453 | 130 | 1,283 | 4 | 26 | 1,673 | 1,383 | 10 |
| Purchase of intangible assets | -547 | -942 | -31 | -346 | -65 | -184 | -1,583 | -293 | -107 | -7,326 | -570 |
| Decrease (increase) in long-term advance payments | - | - | - | -1,152 | -119 | -59 | -955 | - | -310 | -230 | -1,242 |
| Other, net | 72 | - | -1 | -1 | -1 | -1 | -1 | -26 | -1 | -1 | -111 |
| Net cash provided by (used in) investing activities | -6,601 | -1,975 | 999 | -3,319 | -1,534 | -1,073 | -12,024 | -2,616 | -2,345 | -11,271 | -5,240 |
| Net increase (decrease) in short-term borrowings | -1,073 | 118 | -1,189 | - | - | - | - | 1,000 | 6,000 | 1,300 | 3,000 |
| Proceeds from long-term borrowings | 5,850 | - | - | 2,000 | - | - | 7,000 | 4,000 | 1,000 | 7,300 | - |
| Repayments of long-term borrowings | -510 | -921 | -921 | -921 | -1,921 | -653 | -630 | -3,140 | -1,756 | -2,140 | -2,440 |
| Proceeds from issuance of bonds | - | - | - | - | - | - | - | - | - | - | 2,985 |
| Redemption of bonds | - | - | - | - | - | - | - | - | - | - | -300 |
| Dividends paid | -522 | -593 | -675 | -674 | -704 | -794 | -839 | -904 | -807 | -729 | -899 |
| Repayments of lease liabilities | - | - | -341 | -326 | -416 | -513 | -490 | -505 | -476 | -636 | -430 |
| Net cash provided by (used in) financing activities | 3,743 | 1,293 | -4,635 | 78 | -3,042 | -2,001 | 7,265 | 450 | -5,435 | 5,094 | 1,915 |
| Effect of exchange rate change on cash and cash equivalents | 71 | 82 | 30 | -118 | 27 | 49 | -32 | -56 | -55 | 183 | 185 |
| Net increase (decrease) in cash and cash equivalents | 844 | 2,158 | -3,015 | 1,150 | -1,311 | 747 | 2,243 | 3,547 | -1,842 | -6,653 | -1,221 |